HoSE Mandates Delisting of Bamboo Capital (BCG) and TRACODI (TCD) for Violations
This Aveluro analysis covers BCG (Bamboo Capital) on HOSE in the Financial Services sector. The classified event type is regulation change, with negative sentiment and a deterministic market-impact score of 7.0/10. Aveluro classifies this story as a negative catalyst and risk signal for the affected stock. Source coverage came from Tuổi Trẻ - Kinh doanh, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
The Ho Chi Minh City Stock Exchange (HoSE) has announced mandatory delisting procedures for two stocks: BCG of Bamboo Capital Group and TCD of TRACODI Construction Group. BCG faces delisting for repeated failure to file financial statements, while TCD is cited for an audit refusal on its 2024 and 2025 reports. Both companies are part of the same ecosystem, raising governance concerns.
Key Facts
- HoSE notified Bamboo Capital that it has not submitted audited financial statements for 2024 and 2025, semi-annual reviewed reports for 2025, and quarterly reports for Q1-Q4 2025 and Q1 2026.
- BCG is subject to mandatory delisting under HoSE regulations for violating information disclosure obligations.
- TRACODI (TCD) received a similar notice because its auditor, A&C Audit and Consulting Co., Ltd., refused to issue an opinion on the 2024 and 2025 audited financial statements.
- Under current rules, a stock must be delisted if the auditor disclaims an opinion on the most recent annual financial report.
- TRACODI is a member company of the Bamboo Capital ecosystem, and both firms are headquartered in Ho Chi Minh City.
- BCG closed at VND 3, down 0.78% on October 8, 2025, with volume of 14.6 million shares.
What Happened
HoSE issued official notices regarding the potential mandatory delisting of BCG and TCD. For Bamboo Capital, the exchange stated that the company has failed to submit and disclose a series of required financial reports, including audited statements for 2024 and 2025, semi-annual reviewed reports for 2025, and quarterly reports for all of 2025 and Q1 2026. This constitutes a violation of information disclosure obligations, triggering mandatory delisting procedures.
For TRACODI, HoSE cited that its auditor, A&C Audit and Consulting Co., Ltd., refused to issue an opinion on the company’s 2024 and 2025 audited financial statements (both separate and consolidated). Under current regulations, a stock must be delisted if the auditor disclaims an opinion on the most recent annual financial report. Both companies are part of the Bamboo Capital ecosystem, with TRACODI being a member company.
Market Context
BCG trades on HoSE and has been under pressure due to governance issues. The stock closed at VND 3 on October 8, 2025, down 0.78% with high volume of 14.6 million shares, indicating active selling. The broader VN-Index rose 0.39% on the same day, but the delisting news is likely to weigh on BCG and TCD. The construction and conglomerate sectors may face increased scrutiny from investors.
Strategic Significance
The mandatory delisting of BCG and TCD highlights the risks of investing in companies with poor disclosure and audit practices. For Bamboo Capital, the failure to file financial reports for multiple periods suggests deep operational or governance problems. The delisting will remove these stocks from the main exchange, severely limiting liquidity and making it difficult for shareholders to exit. This event may also affect the broader ecosystem of Bamboo Capital, potentially impacting other related entities.
What to Watch
- HoSE’s final decision on the delisting timeline for BCG and TCD.
- Any appeal or remediation efforts by Bamboo Capital or TRACODI to avoid delisting.
- Impact on other stocks within the Bamboo Capital ecosystem.
- Regulatory actions or fines imposed by the State Securities Commission.
- Trading halts or suspension of BCG and TCD prior to delisting.